News & Analysis on Clinical Trial Services & Contract Research And Development
The Bio Affinity Company (BAC) has been contracted to create a purification method for the production of a recombinant protein, the clotting agent factor VIIa, made in the milk of transgenic animals.
A comprehensive review of stimuli-responsive molecularly imprinted polymers (MIPs) in Current Drug Delivery has highlighted their potential within the pharmaceutical industry.
China's Wuxi PharmaTech saw revenues race away across its divisions in the first quarter of 2008, benefitting from the continued shift towards outsourcing of manufacturing and laboratory functions by the pharmaceutical industry.